4
Changes in Ownership
Enliven Therapeutics, Inc. Filed Acc 0001415889-24-013833
Director sold 1,270 shares at $23.74 ($30,150)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Heyman Richard A. Director | 2024-05-16 | Sale 10b5-1 | −1,270 | $23.74 | $30,150 | 135,885 | D: show line 1 in the form |
| Open-market sales · 1,270 sh · avg $23.74 · $30,150 | |||||||
Loading xslF345X05/form4-05202024_110525.xml…